Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,855 | 395 | 99.6% |
| Education | $18.35 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $919.41 | 60 | $0 (2024) |
| PFIZER INC. | $612.25 | 66 | $0 (2019) |
| Novo Nordisk Inc | $408.69 | 29 | $0 (2023) |
| Amgen Inc. | $406.98 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $401.54 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $376.73 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $349.24 | 29 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $169.54 | 32 | $0 (2020) |
| Lilly USA, LLC | $140.61 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $123.41 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.65 | 27 | Amgen Inc. ($144.05) |
| 2023 | $341.08 | 19 | Amgen Inc. ($91.34) |
| 2022 | $177.02 | 11 | Novo Nordisk Inc ($54.27) |
| 2021 | $66.96 | 4 | AstraZeneca Pharmaceuticals LP ($34.08) |
| 2020 | $168.18 | 12 | GlaxoSmithKline, LLC. ($28.35) |
| 2019 | $867.41 | 81 | AstraZeneca Pharmaceuticals LP ($167.64) |
| 2018 | $1,218 | 107 | AstraZeneca Pharmaceuticals LP ($264.35) |
| 2017 | $1,572 | 137 | AstraZeneca Pharmaceuticals LP ($286.68) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: VACCINE | ||||||
| 09/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Bone Health | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: VACCINE | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VACCINE | ||||||
| 08/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes Care | ||||||
| 06/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Bone Health | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiology | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Respiratory | ||||||
| 01/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,649 | 5,151 | $514,176 | $177,290 |
| 2022 | 35 | 3,562 | 5,176 | $541,041 | $170,498 |
| 2021 | 44 | 4,154 | 6,066 | $572,572 | $188,249 |
| 2020 | 38 | 3,798 | 5,792 | $533,787 | $162,216 |
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 300 | 685 | $122,207 | $39,079 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 235 | 235 | $60,266 | $29,259 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 300 | $76,060 | $25,208 | 33.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 251 | 258 | $42,392 | $19,142 | 45.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 48 | $23,418 | $10,058 | 42.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 111 | 111 | $17,514 | $7,906 | 45.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 246 | 407 | $28,093 | $5,329 | 19.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 228 | 304 | $21,387 | $5,004 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 272 | 560 | $8,620 | $4,669 | 54.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 251 | 416 | $26,236 | $4,278 | 16.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 196 | 196 | $6,936 | $3,471 | 50.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 113 | 113 | $4,520 | $3,335 | 73.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 246 | 312 | $14,277 | $2,356 | 16.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 138 | 233 | $6,891 | $2,211 | 32.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 59 | 60 | $10,275 | $2,196 | 21.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 16 | 16 | $6,680 | $2,123 | 31.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $4,198 | $2,048 | 48.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 121 | 188 | $5,944 | $1,662 | 28.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 67 | 67 | $2,376 | $1,193 | 50.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 30 | $3,375 | $954.30 | 28.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 34 | 37 | $3,505 | $944.68 | 27.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 20 | $2,205 | $783.54 | 35.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 40 | 42 | $2,514 | $756.84 | 30.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 17 | $2,166 | $684.76 | 31.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 198 | 208 | $2,324 | $454.08 | 19.5% |
About Dr. Marilyn Landrum, MD
Dr. Marilyn Landrum, MD is a Pediatrics healthcare provider based in Denison, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285683987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marilyn Landrum, MD has received a total of $4,873 in payments from pharmaceutical and medical device companies, with $462.65 received in 2024. These payments were reported across 398 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,855).
As a Medicare-enrolled provider, Landrum has provided services to 15,163 Medicare beneficiaries, totaling 22,185 services with total Medicare billing of $698,253. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Denison, TX
- Active Since 05/09/2006
- Last Updated 01/26/2018
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1285683987
Products in Payments
- FARXIGA (Drug) $385.59
- XARELTO (Drug) $302.81
- LYRICA (Drug) $267.44
- SYMBICORT (Drug) $247.12
- EVENITY (Biological) $182.74
- ANORO (Drug) $174.04
- TROKENDI XR (Drug) $169.54
- TRELEGY ELLIPTA (Drug) $135.34
- CHANTIX (Drug) $132.14
- BREZTRI (Drug) $128.08
- Victoza (Drug) $114.31
- Prolia (Biological) $110.11
- Ozempic (Drug) $101.01
- ENTRESTO (Drug) $100.09
- JARDIANCE (Drug) $99.89
- JANUVIA (Drug) $97.50
- VIAGRA (Drug) $92.56
- Trintellix (Drug) $90.42
- TOVIAZ (Drug) $90.38
- BEVESPI AEROSPHERE (Drug) $85.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Denison
Joseph Lipscomb, M.d, M.D
Pediatrics — Payments: $2,872
Bryan Kalil, M.d, M.D
Pediatrics — Payments: $897.07
Timothy Brumit, Md, MD
Pediatrics — Payments: $556.79
Shannon Hayes, M.d, M.D
Pediatrics — Payments: $382.55
Jeannine Hatt, Md, MD
Pediatrics — Payments: $304.64
David Hayes, M.d, M.D
Pediatrics — Payments: $194.15